Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status
根据KRAS和MEK基因改变状态评估Cobimetinib治疗Rosai-Dorfman病患者的疗效
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2022.4432
Abeykoon, Jithma P; Rech, Karen L; Young, Jason R; Ravindran, Aishwarya; Ruan, Gordon J; Dasari, Surendra; Morlote, Diana M; King, Rebecca L; Rummage, Claire; Zanwar, Saurabh; Acosta-Medina, Aldo M; Tobin, W Oliver; Shah, Mithun V; Bennani, N Nora; Vassallo, Robert; Ryu, Jay H; Koster, Matthew J; Davidge-Pitts, Caroline J; Witzig, Thomas E; Goyal, Gaurav; Go, Ronald S